Exacerbation of methamphetamine-induced neurochemical deficits by melatonin

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 2, 1997, Pages 630-635

  Gibb, James W ^a   Bush, Lloyd ^a   Hanson, Glen R ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; MELATONIN; METHAMPHETAMINE; SEROTONIN; TRYPTOPHAN HYDROXYLASE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG POTENTIATION; ENZYME REGULATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BRAIN CHEMISTRY; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; MALE; MELATONIN; METHAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; TRYPTOPHAN HYDROXYLASE;

EID: 0030831764     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. ALBERS, D., S. AND SONSALLA, P. K.: Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: Pharmacological profile of protective and nonprotective agents. J. Pharmacol. Exp. Ther. 275: 1104-1114, 1995.
2. BAKHIT, C., MORGAN, M. E., PEAT, M. AND GIBB, J. W.: Long-term effects of methamphetamine on the synthesis and metabolism of 5-hydroxytryptophan in various regions of the rat brain. Neuropharmacology 20: 1135-1140, 1981.
3. BOWYER, J. F., TANK, A. W., NEWPORT, G. D., SLIKKER, W., ALI, S. Y. AND HOLSON, R. R.: The influence of environmental temperature on transient effects of methamphetamine on dopamine levels and dopamine release in rat striatum. J. Pharmacol. Exp. Ther. 260: 817-824, 1992.
4. BOWYER, J. F., DAVIES, D. L., SCHMUED, L., BROENING, H. W., NEWPORT, G. D., SLIKKER, W. AND HOLSON, R. R.: Further studies of hyperthermia in methamphetamine neurotoxicity. J. Pharmacol. Exp. Ther. 268: 1571-1580, 1994.
5. CADET, J., SHENG, P., ALI, S., ROTHMAN, R., CARLSON, E. AND EPSTEIN, C.: Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 62: 380-383, 1994.
6. FARFEL, G. M. AND SEIDEN, L. S.: Experiments with methamphetamine, p-chloroamphetamine, fenfluramine, dizocilpine and dextromethorphan. J. Pharmacol. Exp. Ther. 272: 868-875, 1995.
7. FLECKENSTEIN, A. E., GIBB, J. W. AND HANSON, G. R.: Acute effects of methamphetamine on tryptophan hydroxylase activity and oxygen radical formation in rat brain: role of hyperthermia. Abs. Soc. Neurosci. 26: 815.7, 1996.
8. GIBB, J. W. AND KOGAN, F. J.: Influence of dopamine synthesis on methamphetamine-induced change in striatal and adrenal tyrosine hydroxylase activity. N-S Arch. Pharmacol. 310: 185-187, 1979.
9. GIOVANNI, A., LIANG, L., HASTINGS, T. AND ZIGMOND, M. J.: Estimating hydrosyl radical content in rat brain using systemic and intraventricular salicylate: Impact of methamphetamine. J. Neurochem. 64: 1819-1825, 1995.
10. HOTCHKISS, A. J. AND GIBB, J. W.: Long-term effects of multiple doses of methamphetamine on tryptophan hydroxylase activity in rat brain. J. Pharmacol. Exp. Ther. 214: 257-262, 1980.
11. IANAS, O., OLNESCU, R. AND BADESCU, I.: Melatonin involvement in oxidative stress. Rom. J. Endocrinol. 29: 147-153, 1991.
12. JOHNSON, M., STONE, D. M., HANSON, G. R. AND GIBB, J. W.: Role of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system. Eur. J. Pharmacol. 135: 231-234, 1987.
13. JOHNSON, M., ELAYAN, I., HANSON, G. R., FOLTZ, R. L., GIBB, J. W. AND LIM, H. K.: Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems. J. Pharmacol. Exp. Ther. 261: 447-453, 1992.
14. KODA, L. Y. AND GIBB, J. W.: Adrenal and striatal tyrosine hydroxylase activity after methamphetamine. J. Pharmacol. Exp. Ther. 185: 42-48, 1973.
15. KONDO, T., ITO, T. AND SUGITA, Y.: Bromocriptine scavenges methamphetamine-induced hydroxyl radicals and attenuates dopamine depletion in mouse striatum. Ann. N.Y. Acad. Sci. 738: 222-229, 1994.
16. LI, C., WERNER, P. AND COHEN, G.: Lipid peroxidation in brain: Interaction of L-DOPA/dopamine with ascorbate and iron. Neurodegeneration 4: 147-153, 1995.
17. MARSHALL, K-A., REITER, R. J., POEGGELER, B., ARUOMA, O. I. AND HALLIWELL, B.: Evaluation of the antioxidant activity of melatonin in vitro. Free Radical Biol. Med. 21: 307-307, 1996.
18. MATSUDA, L. A., SCHMIDT, C. J., GIBB, J. W. AND HANSON, G. R.: Ascorbic acid-deficient condition alters central effects of methamphetamine. Brain Res. 400: 176-180, 1987.
19. NAGATSU, T., LEVITT, M. AND UDENFRIEND, S.: A rapid and simple radioassay for tyrosine hydroxylase activity. Anal. Biochem. 9: 122-126, 1964.
20. REITER, R.: Oxidative processes and antioxidative defense mechanisims in the aging brain. FASEB J. 9: 526-533, 1995.
21. RICAURTE, G. A., SCHUSTER, C. R. AND SEIDEN, L. S.: Long-term effects of repeated methamphetamine administration on dopamine and serotonin neurons in the rat brain: A regional study. Brain Res. 193: 153-163, 1980.
22. SANDERS-BUSH, E., BUSHING, J. A. AND SULSER, F.: Long-term effects of p-chloroamphetamine on tryptophan hydroxylase activity and on levels of 5-hydroxytryptamine and 5-hydroxyindolactetic acid in brain. Eur. J. Pharmacol. 20: 385-388, 1972.
23. SCHMIDT, C. J., RITTER, J. K., SONSALLA, P. K., HANSON, G. R. AND GIBB, J. W.: Role of dopamine in the neurotoxic effects of methamphetamine. J. Pharmacol. Exp. Ther. 233: 539-544, 1985.
24. SEIDEN, L. S., FISCHMAN, M. W. AND SCHUSTER, C. R.: Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys. Drug Alcohol Depend. 1: 215-219, 1975/76.
25. STONE, D. M., JOHNSON, M., HANSON, G. R. AND GIBB, J. W.: Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine. J. Pharmacol. Exp. Ther. 247: 79-87, 1988.
26. STONE, D. M., HANSON, G. R. AND GIBB, J. W.: In vitro reactivation of rat cortical tryptophan hydroxylase following in vivo inactivation by methylenedioxymethamphetamine. J. Neurochem. 53: 572-581, 1989.
27. TAN, D. X., CHEN, L. D., POEGGELER, B., MANCHESTER, L. C. AND REITER, R. J.: Melatonin: A potent, endogenous hydroxyl radical scavenger. Endocrine J. 1: 57-60, 1993.
28. UNIVERSITY OF CALIFORNIA AT BERKELEY WELLNESS LETTER. 11: 4, 1995.
29. UNIVERSITY OF CALIFORNIA AT BERKELEY WELLNESS LETTER. 12: 1-2, 1996.
30. VISWANATHAN, M., HISSA, R. AND GEORGE, J. C.: Suppression of sympathetic nervous system by short photoperiod and melatonin in the Syrian hamster. Life Sci. 38: 73-79, 1986.